Drugs & Pharmacology Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol ® and Various Formulations of SafeTynadol® in Healthy Volunteers
Conditions: Hepatitis; Pharmacology Interventions: Drug: Panadol; Drug: SafeTynadol® Sponsor: Sinew Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2022 Category: Research Source Type: clinical trials
